NDT Advance Access originally published online on May 17, 2007
Nephrology Dialysis Transplantation 2007 22(9):2678-2685; doi:10.1093/ndt/gfm247
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass
1Department of Nephrology, 2Department of Cardiology, Research Unit, Hospital Universitario de Canarias, Instituto Reina Sofía de Investigación, and 3University of La Laguna, 38320 La Laguna, Tenerife, Spain
Correspondence and offprint requests to: Domingo Hernández, Department of Nephrology, Hospital Universitario de Canarias, E-38320, La Laguna. Tenerife, Spain. Email: dhmarrero{at}hotmail.com; domingohernandez{at}gmail.com
 |
Abstract |
|---|
Background. Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD), including kidney transplant recipients. However, time-related left ventricular mass changes (
LVM) from pre-dialysis stage to beyond the first post-transplant year have not been clearly identified.
Methods. We studied a cohort of 60 stages 4–5 CKD patients without overt cardiac disease, who underwent three echocardiograms during follow-up: at pre-dialysis stage, on dialysis and after kidney transplantation (KT). Multiple linear regression was used to model LVM from baseline study. Cox proportional analysis was used to determine risk factors associated with either de novo LVH or >20% LVMI over time.
Results. Patients with baseline LVH (n = 37; 61%) had a higher body mass index (BMI) than those without LVH (n = 23; 39%) (P = 0.013). BMI, haemoglobin levels (P = 0.047) and non-use of angiotensin-converting enzyme inhibitors (ACEI) (P = 0.057) were associated with baseline left ventricular mass index (LVMI). Twelve out of 23 patients (52%) with normal LVM at baseline, developed either de novo LVH or >20% LVMI at follow-up. On the other hand, 29 (78%) of those with initial LVH maintained this abnormality, and 8 (22%) normalized LVM post-transplantation. Factors associated with LVMI were age (P = 0.01), pre-dialysis LVMI (P < 0.0001), serum creatinine (P = 0.012) and the use of ACEI post-transplantation (P = 0.009). In Cox analysis, pre-dialysis LVMI was associated with de novo LVH or >20% LVMI over time (hazard ratio 1.009; 95% confidence interval 1.004 to 1.015; P = 0.001).
Conclusions. Successful KT may not completely normalize LVM post-transplantation. Pre-dialysis LVMI, traditional risk factors and no use of ACEI may perpetuate cardiac growth following KT.
Keywords: chronic kidney failure; kidney transplantation; left ventricular hypertrophy
Received for publication: 7. 9.06
Accepted in revised form: 30. 3.07
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. S. Gill Cardiovascular Disease in Transplant Recipients: Current and Future Treatment Strategies Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S29 - S37. [Abstract] [Full Text] [PDF]
|
|